At the risk of overdoing it with NAFTA Chapter 19 here on this blog, another question just occurred to me. The bi-national panel system for reviewing domestic AD/CVD decisions started in the Canada - U.S. FTA, and was then brought into NAFTA. But it has never been used in any other U.S. FTA, or for that matter by anyone else anywhere in the world (as far as I know).
Having seen a number of defenses of Chapter 19 recently, let me ask this question to its supporters (and any others who want to weigh in): Should this bi-national panel system be extended to other FTAs? I can't think of anything specific about North American trade that makes Chapter 19 useful only there. If it works, it should work everywhere.
Ultimately, there are three options: (1) Eliminate it from NAFTA; (2) Keep it in NAFTA but do not use it anywhere else; and (3) Incorporate it into other FTAs.
I see why the politics of the issue might lead us to (2), but from a policy perspective, that seems like the strangest outcome.